ストックスクリーナーアプリを入手
233.33
0.97%
2.24
Quest Diagnostics Inc (DGX) 最新ニュース
Quest Diagnostics (DGX) Highlights Haystack MRD Test Accuracy in Colorectal Cancer Trials - GuruFocus
Quest Diagnostics Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Quest Diagnostics Stock Gains 36.3% YTD: What's Behind the Rally? - TradingView
Global Paternity & Relationship Testing Services Market Set for Growth Through 2030 as DNA Testing Demand Expands Across Applications and Product Segments - GlobeNewswire Inc.
Quest Diagnostics (DGX) Could Be 5% Below Fair Value After Apple Health Launch - Yahoo Finance
Quest Diagnostics shows growth potential despite Medicare uncertainties, driven by testing demand and acquisitions. - Pluang
Quest Diagnostics Incorporated: Testing Growth Keeps Me Bullish Despite Medicare Headwinds - Seeking Alpha
Quest Diagnostics Inc (DGX) Stock Down 4.1% but Still Overvalued -- GF Score: 74/100 - GuruFocus
Quest Diagnostics (DGX) Stock Could Be 30% Below Fair Value Following Medicare Payment Cut Concerns - Yahoo Finance
Quest Diagnostics to Release Third Quarter Financial Results on October 22, 2026 - Yahoo Finance
Quest Diagnostics Study Finds High Tick-Borne Disease Co-Exposure - Zacks Investment Research
Why Quest Diagnostics Holdings Stock Dropped Today - Yahoo Finance
Quest Diagnostics, Labcorp Shares Fall as Medicare Signals Cuts in Payment Rates for Lab Services - marketscreener.com
Is This the Right Time to Add DGX Stock to Your Portfolio? - TradingView
Is Quest Diagnostics Stock Outperforming the Nasdaq? - inkl
Evercore sees Lab Corp, Quest shares facing Medicare pricing headwind By Investing.com - Investing.com Canada
Baird Adjusts Price Target on Quest Diagnostics to $260 From $255, Maintains Neutral Rating - marketscreener.com
Labcorp, Quest fall as CMS cuts 2027 rates for laboratory services (LH:NYSE) - Seeking Alpha
Quest Diagnostics Sees Growth Outpace Targets as Consumer Testing Surges - Yahoo Finance
Nearly 1 in 3 people with Lyme antibodies had others too. A parasite found alongside Lyme needs different treatment. - Stock Titan
Truist Raises Price Target on Quest Diagnostics to $260 From $250, Keeps Hold Rating - marketscreener.com
Quest Diagnostics (DGX) Q1 2026 Earnings Call Transcript - Fortune
Quest Diagnostics stock heads into the open after a flat close - AD HOC NEWS
Quest Diagnostics stock gains on strong second quarter figures and Medicare survey impact - AD HOC NEWS
Quest Diagnostics stock heads into the open after a strong recent gain - AD HOC NEWS
Quest Diagnostics Incorporated (DGX) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance
96% say lab tests matter as Medicare cuts approach - Stock Titan
A Look at Quest Diagnostics Inc (DGX) After 3.9% Gain -- GF Value $196.33 vs Price $247.08 - GuruFocus
Quest Diagnostics Inc. stock outperforms competitors on strong trading day - MarketWatch
Why Quest Diagnostics Incorporated (DGX) Stock Is Up Today - Quiver Quantitative
Quest Diagnostics Inc. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
Quest Diagnostics Has Carved Out a Narrow Moat on Its Attractive Cost Structure - Morningstar
Quest Diagnostics Inc. stock underperforms Thursday when compared to competitors - MarketWatch
QUEST DIAGNOSTICS INC : UBS RAISES TARGET PRICE TO $245 FROM $232 - webull.com
Quest Diagnostics Announces Apple Health App Users to Be Able to Order Labs from Quest Diagnostics - marketscreener.com
Apple Health users can buy Quest lab tests for $119 later this year - Stock Titan
UBS raises Quest Diagnostics stock price target on durable volumes By Investing.com - Investing.com Canada
UBS Adjusts Quest Diagnostics Price Target to $245 From $232, Maintains Neutral Rating - marketscreener.com
Quest Diagnostics CEO Sells 10,000 Shares for $2.4 Million - Yahoo Finance
Quest Diagnostics stock edges lower near 52-week highs after solid Q2 growth - ad-hoc-news.de
Man Group takes new $495K stake in Quest Diagnostics as stock nears record high - app.dealroom.co
Quest Diagnostics stock holds steady as investors await next earnings update - ad-hoc-news.de
Quest’s Expanded Alzheimer’s and Wellness Testing Push Might Change The Case For Investing In DGX - Yahoo Finance
CEO of Quest Diagnostics (NYSE: DGX) sells 10,000 shares - Stock Titan
Quest Diagnostics Insider Sold Shares Worth $2,427,200, According to a Recent SEC Filing - marketscreener.com
Quest Diagnostics stock gains as investors focus on growth and fair value - AD HOC NEWS
Quest Diagnostics stock trades near 52-week high as kidney testing deal lifts valuation - AD HOC NEWS
Quest Diagnostics (NYSE: DGX) insider plans new sale after June $1.9M trade - Stock Titan
Quest Diagnostics SVP & general counsel sells $5.5m in shares - Investing.com Nigeria
Quest Diagnostics SVP & general counsel sells $5.5m in shares By Investing.com - Investing.com South Africa
Quest Diagnostics Inc. stock underperforms Monday when compared to competitors - MarketWatch
Quest Diagnostics (DGX) Stock Analysis: Navigating Growth Amidst a Competitive Landscape - DirectorsTalk Interviews
Quest Diagnostics stock holds steady as investors await fresh earnings catalysts - AD HOC NEWS
Quest Diagnostics (NYSE: DGX) holder to sell 22,677 shares - Stock Titan
0.34%
0.08%
大文字化:
|
ボリューム (24 時間):